• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病的治疗策略:聚焦于炎症和纤维化(综述)。

Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).

机构信息

The Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara 634-8522, Japan.

Department of Endoscopy and Ultrasound, Nara Medical University, Kashihara, Nara 634-8522, Japan.

出版信息

Int J Mol Med. 2017 Aug;40(2):263-270. doi: 10.3892/ijmm.2017.3015. Epub 2017 Jun 9.

DOI:10.3892/ijmm.2017.3015
PMID:28627645
Abstract

Excessive alcohol consumption is the most common cause of liver disease in the world. Chronic alcohol abuse leads to liver damage, liver inflammation, fibrosis and hepatocellular carcinoma. Inflammatory cytokines, such as tumor necrosis factor-α and interferon-γ, induce liver injury, which leads to the develo-pment of alcoholic liver disease (ALD). Hepatoprotective cytokines, such as interleukin (IL)-6 and IL-10, are also associated with ALD. IL-6 improves ALD via the activation of STAT3 and the subsequent induction of a variety of hepatoprotective genes in hepatocytes. Alcohol consumption promotes liver inflammation by incre-asing the translocation of gut-derived endotoxins to the portal circulation and by activating Kupffer cells through the lipopolysaccharide/Toll-like receptor 4 pathways. Oxidative stress and microflora products are also associated with ALD. Hepatic stellate cells play an important role in angiogenesis and liver fibrosis. Anti-angiogenic therapy has been found to be effective in the prevention of fibrosis. This suggests that blocking angiogenesis could be a promising therapeutic option for patients with advanced fibrosis. This review discusses the main pathways associated with liver inflammation and liver fibrosis as well as new therapeutic strategies.

摘要

过量饮酒是世界范围内导致肝脏疾病的最常见原因。慢性酒精滥用会导致肝脏损伤、肝脏炎症、纤维化和肝细胞癌。炎症细胞因子,如肿瘤坏死因子-α和干扰素-γ,会诱导肝损伤,从而导致酒精性肝病(ALD)的发生。抗炎细胞因子,如白细胞介素(IL)-6 和 IL-10,也与 ALD 相关。IL-6 通过激活 STAT3 并随后诱导肝细胞中多种肝保护基因的表达来改善 ALD。饮酒通过增加肠道来源的内毒素向门静脉循环的易位,并通过脂多糖/Toll 样受体 4 途径激活枯否细胞来促进肝脏炎症。氧化应激和微生物群落产物也与 ALD 相关。肝星状细胞在血管生成和肝纤维化中发挥重要作用。抗血管生成治疗已被发现可有效预防纤维化。这表明阻断血管生成可能是治疗晚期纤维化患者的一种有前途的治疗选择。本综述讨论了与肝脏炎症和肝纤维化相关的主要途径以及新的治疗策略。

相似文献

1
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).酒精性肝病的治疗策略:聚焦于炎症和纤维化(综述)。
Int J Mol Med. 2017 Aug;40(2):263-270. doi: 10.3892/ijmm.2017.3015. Epub 2017 Jun 9.
2
The effect of inflammatory cytokines in alcoholic liver disease.炎症细胞因子在酒精性肝病中的作用。
Mediators Inflamm. 2013;2013:495156. doi: 10.1155/2013/495156. Epub 2013 Dec 9.
3
Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.Toll样受体介导的信号级联反应作为酒精性肝病炎症网络的调节因子
World J Gastroenterol. 2014 Nov 28;20(44):16443-51. doi: 10.3748/wjg.v20.i44.16443.
4
Microbiota-based treatments in alcoholic liver disease.基于微生物群的酒精性肝病治疗方法。
World J Gastroenterol. 2016 Aug 7;22(29):6673-82. doi: 10.3748/wjg.v22.i29.6673.
5
Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.酒精性肝病中的肝保护和抗炎细胞因子。
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2(Suppl 2):89-93. doi: 10.1111/j.1440-1746.2011.07003.x.
6
Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury.罗伊氏乳杆菌 GG 减少慢性酒精性肝损伤中肝脏 TNFα 的产生和炎症。
J Nutr Biochem. 2013 Sep;24(9):1609-15. doi: 10.1016/j.jnutbio.2013.02.001. Epub 2013 Apr 22.
7
Are Probiotics Effective in Targeting Alcoholic Liver Diseases?益生菌在靶向治疗酒精性肝病方面有效吗?
Probiotics Antimicrob Proteins. 2019 Jun;11(2):335-347. doi: 10.1007/s12602-018-9419-6.
8
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.代谢性炎症在非酒精性脂肪性肝病中作为肝纤维化的启动因素。
World J Gastroenterol. 2020 May 7;26(17):1993-2011. doi: 10.3748/wjg.v26.i17.1993.
9
Gut-liver axis in alcoholic liver disease.酒精性肝病中的肠-肝轴
Gastroenterology. 2015 Jan;148(1):30-6. doi: 10.1053/j.gastro.2014.10.042. Epub 2014 Nov 11.
10
Decoding cell death signals in liver inflammation.解析肝炎症中的细胞死亡信号。
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.

引用本文的文献

1
Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity.包含索拉非尼和常春藤皂苷元衍生物的共组装纳米颗粒用于增强抗肝纤维化活性
Int J Nanomedicine. 2025 Jul 18;20:9135-9153. doi: 10.2147/IJN.S512005. eCollection 2025.
2
Emerging role of natural bioactive compounds in navigating the future of liver disease.天然生物活性化合物在引领肝病未来发展中的新作用。
ILIVER. 2024 Dec 13;4(1):100140. doi: 10.1016/j.iliver.2024.100140. eCollection 2025 Mar.
3
Subacute exposure to apigenin induces changes in protein synthesis in the liver of Swiss mice.
亚急性暴露于芹菜素会诱导瑞士小鼠肝脏中蛋白质合成的变化。
Front Physiol. 2025 May 9;16:1576310. doi: 10.3389/fphys.2025.1576310. eCollection 2025.
4
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease.细胞因子在酒精性肝病发病机制及治疗中的作用
Diseases. 2024 Mar 29;12(4):69. doi: 10.3390/diseases12040069.
5
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?酒精性和非酒精性脂肪肝的下游常见分子事件有哪些?
Lipids Health Dis. 2024 Feb 8;23(1):41. doi: 10.1186/s12944-024-02031-1.
6
[Quercetin induces hepatic stellate cell apoptosis by inhibiting the PI3K/Akt signaling pathway upregulating miR-146].槲皮素通过抑制PI3K/Akt信号通路并上调miR-146诱导肝星状细胞凋亡
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Oct 20;43(10):1725-1733. doi: 10.12122/j.issn.1673-4254.2023.10.10.
7
NLRP3: a new therapeutic target in alcoholic liver disease.NLRP3:酒精性肝病的新治疗靶点。
Front Immunol. 2023 Jul 13;14:1215333. doi: 10.3389/fimmu.2023.1215333. eCollection 2023.
8
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight.桦木酸通过调节 NOX/p38 MAPK/PPARα 通路和 miR-155 的表达减轻实验性酒精性肝病小鼠模型的肝损伤:新的机制见解。
Arch Pharm Res. 2023 Apr;46(4):323-338. doi: 10.1007/s12272-023-01441-6. Epub 2023 Mar 23.
9
-Derived Postbiotics Ameliorate Acute Alcohol-Induced Liver Injury by Protecting Cells from Oxidative Damage, Improving Lipid Metabolism, and Regulating Intestinal Microbiota.后生元通过保护细胞免受氧化损伤、改善脂质代谢和调节肠道微生物群来改善急性酒精性肝损伤。
Nutrients. 2023 Feb 7;15(4):845. doi: 10.3390/nu15040845.
10
Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease.酒精性肝病的治疗选择现状及间充质干细胞治疗的潜力
Cells. 2022 Dec 21;12(1):22. doi: 10.3390/cells12010022.